A Left‐Handed Solution to Peptide Inhibition of the p53–MDM2 Interaction

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

Synthesis of Proteins by Native Chemical Ligation

Dawson, P. E., Muir, T. W., Clark‐Lewis, I., & Kent, S. B. H. (1994) · Science · doi:10.1126/science.7973629 · Cited by 4,142 · see citing works

How to measure and predict the molar absorption coefficient of a protein

Pace, C., Vajdos, F., Fee, L. R., Grimsley, G., & Gray, T. (1995) · Protein Science · doi:10.1002/pro.5560041120 · Cited by 3,924 · see citing works

p53 in health and disease

Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,275 · see citing works

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · see citing works

Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · see citing works

Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349 · see citing works

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works

In situ neutralization in Boc‐chemistry solid phase peptide synthesis

Schnölzer, M., Alewood, P. F., Jones, A., Alewood, D., & Kent, S. B. H. (1992) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1992.tb00291.x · Cited by 1,052 · see citing works

An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides

Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037 · see citing works

Total chemical synthesis of proteins

Kent, S. B. H. (2008) · Chemical Society Reviews · doi:10.1039/b700141j · Cited by 927 · see citing works

Awakening guardian angels: drugging the p53 pathway

Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · see citing works

Direct inhibition of the NOTCH transcription factor complex

Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752 · see citing works

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708917105 · Cited by 660 · see citing works

Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide

Bernal, F., Tyler, A. F., Korsmeyer, S. J., Walensky, L. D., & Verdine, G. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0693587 · Cited by 559 · see citing works

Inhibiting HIV-1 Entry

Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442 · see citing works

Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX

Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., Li, J., Monbo, J., Zella, D., Tarasov, S. G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900947106 · Cited by 391 · see citing works

Identification of d -Peptide Ligands Through Mirror-Image Phage Display

Schumacher, T. N., Mayr, L. M., Minor, D. L., Milhollen, M. A., Burgess, M. W., & Kim, P. S. (1996) · Science · doi:10.1126/science.271.5257.1854 · Cited by 377 · see citing works

Molecular Mechanism of the Interaction between MDM2 and p53

Schön, O., Friedler, A., Bycroft, M., Freund, S. M. V., & Fersht, A. R. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00852-5 · Cited by 349 · see citing works

β-Hairpin Peptidomimetics: Design, Structures and Biological Activities

Robinson, J. A. (2008) · Accounts of Chemical Research · doi:10.1021/ar700259k · Cited by 321 · see citing works

Molecular characterization of the hdm2-p53 interaction 1 1Edited by J. Karn

Böttger, A., Böttger, V., Garcı́a-Echeverrı́a, C., Chêne, P., Hochkeppel, H. K., Sampson, W. R., Ang, K. H., Howard, S. F., Picksley, S. M., & Lane, D. P. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1078 · Cited by 251 · see citing works

MDMX: from bench to bedside

Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works

Efficient p53 Activation and Apoptosis by Simultaneous Disruption of Binding to MDM2 and MDMX

Hu, B., Gilkes, D. M., & Chen, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1140 · Cited by 214 · see citing works

Targeting protein–protein interactions: Lessons from p53/MDM2

Murray, J. K., & Gellman, S. H. (2007) · Biopolymers · doi:10.1002/bip.20741 · Cited by 186 · see citing works

Using a β‐Hairpin To Mimic an α‐Helix: Cyclic Peptidomimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction

Fasan, R., Dias, R. L. A., Moehle, K., Zerbe, O., Vrijbloed, J. W., Obrecht, D., & Robinson, J. A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353242 · Cited by 183 · see citing works

Miniature Protein Inhibitors of the p53–hDM2 Interaction

Kritzer, J. A., Zutshi, R., Cheah, M. T., Ran, F. A., Webman, R. B., Wongjirad, T. M., & Schepartz, A. (2006) · ChemBioChem · doi:10.1002/cbic.200500324 · Cited by 87 · see citing works

Apamin as a Template for Structure‐Based Rational Design of Potent Peptide Activators of p53

Li, C., Pazgier, M., Liu, M., Lu, W., & Lu, W. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904550 · Cited by 79 · see citing works

Turning a Scorpion Toxin into an Antitumor Miniprotein

Li, C., Liu, M., Monbo, J., Zou, G., Li, C., Yuan, W., Zella, D., Lu, W., & Lu, W. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8042036 · Cited by 75 · see citing works

Using a β‐Hairpin To Mimic an α‐Helix: Cyclic Peptidomimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction

Fasan, R., Dias, R. L. A., Moehle, K., Zerbe, O., Vrijbloed, J. W., Obrecht, D., & Robinson, J. A. (2004) · Angewandte Chemie · doi:10.1002/ange.200353242 · Cited by 48 · see citing works

Apamin as a Template for Structure‐Based Rational Design of Potent Peptide Activators of p53

Li, C., Pazgier, M., Liu, M., Lu, W., & Lu, W. (2009) · Angewandte Chemie · doi:10.1002/ange.200904550 · Cited by 16 · see citing works

Structure‐Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes

Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412070 · Cited by 718 · see citing works

Modulators of Protein–Protein Interactions

Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497 · see citing works

Blocking of the PD‐1/PD‐L1 Interaction by a D ‐Peptide Antagonist for Cancer Immunotherapy

Chang, H., Liu, B., Qi, Y., Zhou, Y., Chen, Y., Pan, K., Li, W., Zhou, X., Ma, W., Fu, C., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506225 · Cited by 401 · see citing works

D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms

Liu, M., Li, C., Pazgier, M., Li, C., Mao, Y., Lv, Y., Gu, B., Wei, G., Yuan, W., Zhan, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008930107 · Cited by 229 · see citing works

Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction

Yan, J., Yao, Y., Yan, S., Gao, R., Lu, W., & He, W. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01757 · Cited by 212 · see citing works

Peptide-based inhibitors of protein–protein interactions

Wójcik, P., & Berlicki, Ł. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.084 · Cited by 177 · see citing works

Synthesis and folding of a mirror-image enzyme reveals ambidextrous chaperone activity

Weinstock, M. T., Jacobsen, M. T., & Kay, M. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410900111 · Cited by 142 · see citing works

Mirror-image protein and peptide drug discovery through mirror-image phage display

Qi, Y., Zheng, J., & Liu, L. (2024) · Chem · doi:10.1016/j.chempr.2024.06.004 · Cited by 122 · see citing works

Synthesis and applications of mirror-image proteins

Harrison, K., Mackay, A. S., Kambanis, L., Maxwell, J. W. C., & Payne, R. J. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00493-y · Cited by 104 · see citing works

Protease‐resistant peptide design—empowering nature's fragile warriors against HIV

Weinstock, M. T., Francis, J. N., Redman, J. S., & Kay, M. S. (2012) · Biopolymers · doi:10.1002/bip.22073 · Cited by 91 · see citing works

Strukturbasierte Entwicklung von Protein‐Protein‐Interaktionsinhibitoren: Stabilisierung und Nachahmung von Peptidliganden

Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie · doi:10.1002/ange.201412070 · Cited by 90 · see citing works

Enhanced cellular uptake and nuclear accumulation of drug-peptide nanomedicines prepared by enzyme-instructed self-assembly

Liang, C., Yan, X., Zhang, R., Xu, T., Zheng, D., Tan, Z., Chen, Y., Gao, Z., Wang, L., Li, X., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.028 · Cited by 89 · see citing works

An Ultrahigh Affinity d -Peptide Antagonist Of MDM2

Zhan, C., Zhao, L., Wei, X., Wu, X., Chen, X., Yuan, W., Lu, W., Pazgier, M., & Lu, W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3005465 · Cited by 80 · see citing works

Limitations of Peptide Retro-inverso Isomerization in Molecular Mimicry

Li, C., Pazgier, M., Li, J., Li, C., Liu, M., Zou, G., Li, Z., Chen, J., Tarasov, S. G., Lu, W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116814 · Cited by 79 · see citing works

Peptidomimetics: A Synthetic Tool for Inhibiting Protein–Protein Interactions in Cancer

Mabonga, L., & Kappo, A. P. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09831-5 · Cited by 78 · see citing works

D‐Peptides as Recognition Molecules and Therapeutic Agents

Liu, M., Li, X., Xie, Z., Xie, C., Zhan, C., Hu, X., Shen, Q., Wei, X., Su, B., Wang, J., et al. (2016) · The Chemical Record · doi:10.1002/tcr.201600005 · Cited by 77 · see citing works

Unnatural helical peptidic foldamers as protein segment mimics

Sang, P., & Cai, J. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00395c · Cited by 77 · see citing works

Targeting protein−protein interfaces using macrocyclic peptides

Gao, M., Cheng, K., & Yin, H. H. (2015) · Biopolymers · doi:10.1002/bip.22625 · Cited by 72 · see citing works

Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design

Li, X., Tolbert, W. D., Hu, H., Gohain, N., Zou, Y., Niu, F., He, W., Yuan, W., Su, J., Pazgier, M., et al. (2018) · Chemical Science · doi:10.1039/c8sc03275k · Cited by 71 · see citing works

Functional peptide-based drug delivery systems

Lian, Z., & Ji, T. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00713g · Cited by 71 · see citing works

Stabilized helical peptides: overview of the technologies and therapeutic promises

Estieu‐Gionnet, K., & Guichard, G. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.603723 · Cited by 71 · see citing works

Designing helical peptide inhibitors of protein–protein interactions

Araghi, R. R., & Keating, A. E. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.04.001 · Cited by 64 · see citing works

AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein–Protein Interaction Interfaces

Rooklin, D. W., Wang, C., Katigbak, J., Arora, P. S., & Zhang, Y. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00103 · Cited by 66 · see citing works

Mirror image proteins

Zhao, L., & Lu, W. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.09.019 · Cited by 62 · see citing works

Identification of water-soluble peptides in distilled spent grain and its angiotensin converting enzyme (ACE) inhibitory activity based on UPLC-Q-TOF-MS and proteomics analysis

Wei, D., Fan, W., & Xu, Y. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.129521 · Cited by 57 · see citing works

Backbone‐Installed Split Intein‐Assisted Ligation for the Chemical Synthesis of Mirror‐Image Proteins

Zhang, B., Zheng, Y., Chu, G., Deng, X., Wang, T., Shi, W., Zhou, Y., Tang, S., Zheng, J., & Liu, L. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202306270 · Cited by 56 · see citing works

Total Chemical Synthesis and Folding of All- l and All- d Variants of Oncogenic KRas(G12V)

Levinson, A. M., McGee, J. H., Roberts, A. G., Creech, G. S., Wang, T., Peterson, M. T., Hendrickson, R. C., Verdine, G. L., & Danishefsky, S. J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02988 · Cited by 55 · see citing works

Peptide and protein mimetics by retro and retroinverso analogs

Rai, J. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13472 · Cited by 51 · see citing works

Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins

Callahan, A. J., Gandhesiri, S., Travaline, T. L., Reja, R. M., Salazar, L. L., Hanna, S., Lee, Y., Li, K., Tokareva, O. S., Swiecicki, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45634-z · Cited by 50 · see citing works

Interrogation of MDM2 Phosphorylation in p53 Activation Using Native Chemical Ligation: The Functional Role of Ser17 Phosphorylation in MDM2 Reexamined

Zhan, C., Varney, K. M., Yuan, W., Zhao, L., & Lu, W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301255n · Cited by 49 · see citing works

An Update on MDMX and Dual MDM2/X Inhibitors

Espadinha, M., Barcherini, V., Lopes, E. A., & Santos, M. M. M. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180604080119 · Cited by 49 · see citing works

An NRP1/MDM2‐Targeted D‐Peptide Supramolecular Nanomedicine for High‐Efficacy and Low‐Toxic Liver Cancer Therapy

Zhou, Y., Chen, Y., Tan, Y., Hu, R., & Niu, M. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002197 · Cited by 44 · see citing works

Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics

Swenson, C., Mandava, G., Thomas, D. M., & Moellering, R. E. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00423 · Cited by 48 · see citing works

Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery

Bian, Z., Yan, J., Wang, S., Li, Y., Guo, Y., Ma, B., Guo, H., Lei, Z., Yin, C., Zhou, Y., et al. (2018) · Theranostics · doi:10.7150/thno.27165 · Cited by 45 · see citing works

Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression

Li, X., Gohain, N., Chen, S., Li, Y., Zhao, X., Li, B., Tolbert, W. D., He, W., Pazgier, M., Hu, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.010 · Cited by 44 · see citing works

Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch

He, W., Yan, J., Jiang, W., Li, S., Qu, Y., Niu, F., Yan, Y., Sui, F., Wang, S., Zhou, Y., et al. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b02572 · Cited by 41 · see citing works

A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy

Ma, B., Niu, F., Qu, X., He, W., Feng, C., Wang, S., Ouyang, Z., Yan, J., Wen, Y., Xu, D., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.03.004 · Cited by 39 · see citing works

Foldamers in Medicinal Chemistry

Pasco, M., Dolain, C., & Guichard, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12565-x · Cited by 38 · see citing works

Macrocyclization of an all- d linear α-helical peptide imparts cellular permeability

Kannan, S., Aronica, P. G. A., Ng, S., Lian, D. T. G., Frosi, Y., Chee, S. M. Q., Jiang, S., Yuen, T. Y., Sadruddin, A., Kaan, H. Y. K., et al. (2020) · Chemical Science · doi:10.1039/c9sc06383h · Cited by 38 · see citing works

Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53–MDM2 interaction

Li, C., Zhan, C., Zhao, L., Chen, X., Lu, W., & Lu, W. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.039 · Cited by 37 · see citing works

Molecular mechanism of interactions between inhibitory tripeptide GEF and angiotensin-converting enzyme in aqueous solutions by molecular dynamic simulations

Qi, C., Zhang, R., Liu, F., Zheng, T., & Wu, W. (2017) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2017.11.033 · Cited by 37 · see citing works

Rational Design of Right-Handed Heterogeneous Peptidomimetics as Inhibitors of Protein–Protein Interactions

Shi, Y., Sang, P., Lu, J., Higbee, P. S., Chen, L., Yang, L., Odom, T., Daughdrill, G. W., Chen, J., & Cai, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01638 · Cited by 31 · see citing works

Mirror image phage display – Generating stable therapeutically and diagnostically active peptides with biotechnological means

Sun, N., Funke, S. A., & Willbold, D. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.05.019 · Cited by 28 · see citing works

Molecular mechanism of the interactions between inhibitory tripeptides and angiotensin-converting enzyme

Zhou, M., Du, K., Ji, P., & Feng, W. (2012) · Biophysical Chemistry · doi:10.1016/j.bpc.2012.05.002 · Cited by 26 · see citing works

Chemical Synthesis of Proteins that cannot be Obtained Recombinantly

Liu, L. (2018) · Israel Journal of Chemistry · doi:10.1002/ijch.201800135 · Cited by 25 · see citing works

Development of Mirror-Image Screening Systems for XIAP BIR3 Domain Inhibitors

Shu, K., Iwamoto, N., Honda, K., Kondoh, Y., Hirano, H., Osada, H., Ohno, H., Fujii, N., & Oishi, S. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00154 · Cited by 25 · see citing works

Phage nanofibers in nanomedicine: Biopanning for early diagnosis, targeted therapy, and proteomics analysis

Xu, H. W., Cao, B., Li, Y., & Mao, C. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1623 · Cited by 25 · see citing works

Affinity-based screening of MDM2/MDMX–p53 interaction inhibitors by chemical array: Identification of novel peptidic inhibitors

Noguchi, T., Oishi, S., Honda, K., Kondoh, Y., Saito, T., Kubo, T., Kaneda, M., Ohno, H., Osada, H., & Fujii, N. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.094 · Cited by 24 · see citing works

Aligator: A computational tool for optimizing total chemical synthesis of large proteins

Jacobsen, M. T., Erickson, P. W., & Kay, M. S. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.061 · Cited by 24 · see citing works

Molecular Engineering of Peptide–Drug Conjugates for Therapeutics

Fang, Y., & Wang, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010212 · Cited by 24 · see citing works

Nanosensing protein allostery using a bivalent mouse double minute two (MDM2) assay

Robson, A. F., Hupp, T. R., Lickiss, F., Ball, K. L., Faulds, K., & Graham, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116637109 · Cited by 24 · see citing works

Peptide Activators of the p53 Tumor Suppressor

Zhan, C., & Lu, W. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795222577 · Cited by 23 · see citing works

Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review

Teveroni, E., Lucà, R., Pellegrino, M., Ciolli, G., Pontecorvi, A., & Moretti, F. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1233179 · Cited by 23 · see citing works

The Potential of Peptide-Based Inhibitors in Disrupting Protein–Protein Interactions for Targeted Cancer Therapy

Afonso, A. L., Cavaleiro, C. T., Castanho, M. A. R. B., Neves, V., & Cavaco, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073117 · Cited by 23 · see citing works

Screening of a virtual mirror-image library of natural products

Noguchi, T., Oishi, S., Honda, K., Kondoh, Y., Saito, T., Ohno, H., Osada, H., & Fujii, N. (2016) · Chemical Communications · doi:10.1039/c6cc03114e · Cited by 22 · see citing works

L‐Glycosidase‐Cleavable Natural Glycans Facilitate the Chemical Synthesis of Correctly Folded Disulfide‐Bonded D‐Proteins

Shi, W., Wang, T., Yang, Z., Ren, Y., Han, D., Zheng, Y., Deng, X., Tang, S., & Zheng, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202313640 · Cited by 21 · see citing works

Markov models of the apo-MDM2 lid region reveal diffuse yet two-state binding dynamics and receptor poses for computational docking

Mukherjee, S., Pantelopulos, G. A., & Voelz, V. A. (2016) · Scientific Reports · doi:10.1038/srep31631 · Cited by 20 · see citing works

Generating a mirror-image monobody targeting MCP-1 via TRAP display and chemical protein synthesis

Hayashi, G., Naito, T., Miura, S., Iwamoto, N., Usui, Y., Bando-Shimizu, M., Suzuki, S., Higashi, K., Nonaka, M., Oishi, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54902-x · Cited by 20 · see citing works

Targeted delivery of a novel palmitylated D-peptide for antiglioblastoma molecular therapy

Li, C. V., Shen, J., Wei, X., Xie, C., & Lu, W. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2011.645162 · Cited by 20 · see citing works

An Enzyme‐Cleavable Solubilizing‐Tag Facilitates the Chemical Synthesis of Mirror‐Image Proteins

Zheng, Y., Zhang, B., Shi, W., Deng, X., Wang, T., Han, D., Ren, Y., Yang, Z., Zhou, Y., Kuang, J., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202318897 · Cited by 18 · see citing works

Simulating Molecular Mechanisms of the MDM2-Mediated Regulatory Interactions: A Conformational Selection Model of the MDM2 Lid Dynamics

Verkhivker, G. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040897 · Cited by 18 · see citing works

Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)

Macchiarulo, A., Giacchè, N., Carotti, A., Moretti, F., & Pellicciari, R. (2011) · MedChemComm · doi:10.1039/c0md00238k · Cited by 16 · see citing works

Effect of Sequence and Stereochemistry Reversal on p53 Peptide Mimicry

Atzori, A., Baker, A. E., Chiu, M., Bryce, R. A., & Bonnet, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068723 · Cited by 16 · see citing works

Innovative Peptide Therapeutics in the Pipeline: Transforming Cancer Detection and Treatment

Nsereko, Y., Armstrong, A. J., Coburn, F., & Musaimi, O. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146815 · Cited by 14 · see citing works

Solution-State Preorganization of Cyclic β-Hairpin Ligands Determines Binding Mechanism and Affinities for MDM2

Ge, Y., Zhang, S., Erdélyi, M., & Voelz, V. A. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00029 · Cited by 14 · see citing works

Blocking of the PD‐1/PD‐L1 Interaction by a D ‐Peptide Antagonist for Cancer Immunotherapy

Chang, H., Liu, B., Qi, Y., Zhou, Y., Chen, Y., Pan, K., Li, W., Zhou, X., Ma, W., Fu, C., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201506225 · Cited by 14 · see citing works

Molecular dynamics investigation on the interaction of human angiotensin-converting enzyme with tetrapeptide inhibitors

Liu, X., Wang, Z., Gao, Y., Liu, C., Wang, J., Li, F., Min, W., & Zhang, J. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp00172h · Cited by 14 · see citing works

Single-Shot Flow Synthesis of D-Proteins for Mirror-Image Phage DisplayPreprint

Callahan, A. J., Gandhesiri, S., Travaline, T. L., Salazar, L. L., Hanna, S., Lee, Y., Li, K., Tokareva, O. S., Swiecicki, J., Loas, A., et al. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-x86xp · Cited by 16 · see citing works

Peptide inhibitors: Breaking cancer code

Coburn, F., Nsereko, Y., Armstrong, A. J., & Musaimi, O. A. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117961 · Cited by 13 · see citing works

Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning

Yang, W., Wang, J., Zhao, L., & Chen, J. (2024) · Molecules · doi:10.3390/molecules29143377 · Cited by 13 · see citing works

Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds

Izumi, H., Nafié, L. A., & Dukor, R. K. (2021) · ACS Omega · doi:10.1021/acsomega.1c03055 · Cited by 12 · see citing works

Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades

Carrera-Aubesart, A., Gallo, M., Defaus, S., Todorovski, T., & Andreu, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102451 · Cited by 11 · see citing works

Investigation of the inhibitory mechanism of apomorphine against MDM2–p53 interaction

Ishiba, H., Noguchi, T., Shu, K., Ohno, H., Honda, K., Kondoh, Y., Osada, H., Fujii, N., & Oishi, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.082 · Cited by 10 · see citing works

Discovery of d -Miniprotein Inhibitors of PD-1/PD-L1 Interaction via Mirror-Image Phage Display against Synthetic d -PD-1

Zhou, H., Wu, H., Zhong, Z., Blasco, P., Zeng, J., Wang, J., Liu, H., & Li, X. (2025) · JACS Au · doi:10.1021/jacsau.5c01181 · Cited by 10 · see citing works

Nuclear delivery of dual anti-cancer drugs by molecular self-assembly

Wu, J., Ding, W., Han, G., You, W., Gao, W., Shen, H., Tang, J., Tang, Q., & Wang, X. (2020) · Biomaterials Science · doi:10.1039/d0bm00971g · Cited by 10 · see citing works

Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation

Micewicz, E. D., Sharma, S. K., Waring, A. J., Luong, H. T., McBride, W. H., & Ruchala, P. P. (2015) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-015-9487-3 · Cited by 11 · see citing works

Targeted Nanoswitchable Inhibitors of Protein–Protein Interactions Involved in Apoptosis

Nevola, L., Varese, M., Martín‐Quirós, A., Mari, G., Eckelt, K., Gorostiza, P., & Giralt, E. (2018) · ChemMedChem · doi:10.1002/cmdc.201800647 · Cited by 10 · see citing works

Probing the Sophisticated Synergistic Allosteric Regulation of Aromatic Amino Acid Biosynthesis in Mycobacterium tuberculosis Using ᴅ-Amino Acids

Reichau, S., Blackmore, N. J., Jiao, W., & Parker, E. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152723 · Cited by 9 · see citing works

Rapid identification of dual p53-MDM2/MDMX interaction inhibitors through virtual screening and hit-based substructure search

Chen, S., Li, X., Yuan, W., Zou, Y., Guo, Z., Chai, Y., & Lu, W. (2017) · RSC Advances · doi:10.1039/c7ra00473g · Cited by 9 · see citing works

Preparation, identification, and molecular docking of novel angiotensin‐converting enzyme inhibitory peptides derived from rice‐based distillers' spent cakes

Su, H., Fan, W., Xu, Y., Tang, S. J., Yue, D., & Liao, Z. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13474 · Cited by 7 · see citing works

Facile synthesis, optical and conformational characteristics, and efficient intracellular delivery of a peptide–DNA conjugate

Lee, M.-K., & Lim, Y. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.041 · Cited by 7 · see citing works

Sensitive and simultaneous surface plasmon resonance detection of free and p53-bound MDM2 proteins from human sarcomas

Wu, L., Tang, H., Hu, S., Xia, Y., Lu, Z., Fan, Y., Wang, Z., Yi, X., Zhou, F., & Wang, J. (2018) · The Analyst · doi:10.1039/c7an01918a · Cited by 7 · see citing works

Rigorous Computational and Experimental Investigations on MDM2/MDMX-Targeted Linear and Macrocyclic Peptides

Diller, D., Swanson, J., Bayden, A. S., Brown, C. J., Thean, D., Lane, D. P., Partridge, A. W., Sawyer, T. K., & Audie, J. (2019) · Molecules · doi:10.3390/molecules24244586 · Cited by 7 · see citing works

Rapid Production of Native and Mirror-Image Tumor Necrosis Factor-α Enabled by Automated Flow Peptide Synthesis Technology

Yeşilçimen, A., Callahan, A. J., Travaline, T. L., Gandhesiri, S., Tokareva, O. S., Loas, A., McGee, J. H., & Pentelute, B. L. (2024) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.4c01866 · Cited by 6 · see citing works

Inhibiting mechanism of small molecule toward the p53‐ MDM 2 interaction: A molecular dynamic exploration

Chen, J., Wang, J., Pang, L., & Zhu, W. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13345 · Cited by 6 · see citing works

Total chemical synthesis of human interferon alpha‐2b via native chemical ligation

Li, J., Lehmann, C., Chen, X., Romerio, F., & Lu, W. (2015) · Journal of Peptide Science · doi:10.1002/psc.2760 · Cited by 6 · see citing works

Protein Chemical Synthesis in Drug Discovery

Liu, F., & Mayer, J. P. (2014) · Topics in current chemistry · doi:10.1007/128_2014_598 · Cited by 5 · see citing works

A dimethylbromobenzene-cysteine stapled peptide dual inhibitor of the p53-MDM2/MDMX interactions

Jiang, W., Jin, L., Liu, M., Hou, P., & He, W. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2018.97 · Cited by 5 · see citing works

A Dual-Specificity d -Peptide Antagonist of MDM2 and MDMX for Antitumor Immunotherapy

Liao, C., Yan, J., Tolbert, W. D., Chen, X., Pazgier, M., Lu, W., Zhan, C., & Lu, W. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02057 · Cited by 4 · see citing works

Chemical Synthesis, Refolding, and Characterization of Mirror-Image Cyclophilin A

Yeşilçimen, A., Gandhesiri, S., Travaline, T. L., Callahan, A. J., Tokareva, O. S., Loas, A., McGee, J. H., & Pentelute, B. L. (2025) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.4c03049 · Cited by 4 · see citing works

Protein–Protein Interaction Inhibitors in Cancer

Hardcastle, I. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12392-3 · Cited by 4 · see citing works

Design and Evaluation of Stable Cysteine-Modified Monobody Scaffolds for Mirror-Image Synthesis

Iwamoto, N., Ohno, S., Nakamura, K., Naito, T., Miura, S., Inuki, S., Ohno, H., Hayashi, G., Murakami, H., & Oishi, S. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00181 · Cited by 3 · see citing works

Tailoring peptides and peptidomimetics for targeting protein–protein interactions

Berlicki, Ł. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820141-1.00009-1 · Cited by 3 · see citing works

Backbone‐Installed Split Intein‐Assisted Ligation for the Chemical Synthesis of Mirror‐Image Proteins

Zhang, B., Zheng, Y., Chu, G., Deng, X., Wang, T., Shi, W., Zhou, Y., Tang, S., Zheng, J., & Liu, L. (2023) · Angewandte Chemie · doi:10.1002/ange.202306270 · Cited by 3 · see citing works

Peptide‑based therapeutic strategies for glioma: Current state and prospects

Mi, Y., Jiang, P., Luan, J., Feng, L., Zhang, D., & Gao, X. (2025) · Peptides · doi:10.1016/j.peptides.2025.171354 · Cited by 3 · see citing works

Targeting the MDM2–p53 Protein–Protein Interaction

Hardcastle, I. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00013-9 · Cited by 3 · see citing works

Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality

Zhang, X., Yue, H.-W., Liu, Y., Wang, J., Duan, H.-T., Liu, Y.-H., Jiang, L., & Hu, H. (2025) · iScience · doi:10.1016/j.isci.2025.112025 · Cited by 2 · see citing works

Stapled peptidomimetic therapeutics

Kannan, S., Lama, D., Tan, Y. S., Li, J., & Verma, C. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820141-1.00022-4 · Cited by 1 · see citing works

Chirality in a quaternionic representation of the genetic code

Carlevaro, C. M., Irastorza, R. M., & Vericat, F. (2016) · Biosystems · doi:10.1016/j.biosystems.2016.06.003 · Cited by 1 · see citing works

In silico design of anti-tumor mini-protein targeting MDM2

Zhang, J., Xu, H., Wang, B., Zhang, X., Fu, L., Li, Y., Wu, G., Zhao, Z., Liu, L., Yang, T., et al. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.107871 · Cited by 1 · see citing works

An Ultrahigh Affinity d -Peptide Antagonist Of MDM2

Zhan, C., Zhao, L., Wei, X., Wu, X., Chen, X., Yuan, W., Lu, W., Pazgier, M., & Lu, W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3005465 · Cited by 80 · see citing works

D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms

Liu, M., Li, C., Pazgier, M., Li, C., Mao, Y., Lv, Y., Gu, B., Wei, G., Yuan, W., Zhan, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008930107 · Cited by 229 · see citing works

Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression

Li, X., Gohain, N., Chen, S., Li, Y., Zhao, X., Li, B., Tolbert, W. D., He, W., Pazgier, M., Hu, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.010 · Cited by 44 · see citing works

Identification of novel mdm2 binding peptides by phage display.

Böttger, V., Böttger, A., Howard, S. F., Picksley, S. M., Chêne, P., Garcı́a-Echeverrı́a, C., Hochkeppel, H. K., & Lane, D. P. (1996) · PubMed · Cited by 182 · see citing works

mRNA Display Selection of an Optimized MDM2-Binding Peptide That Potently Inhibits MDM2-p53 Interaction

Shiheido, H., Takashima, H., Doi, N., & Yanagawa, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017898 · Cited by 33 · see citing works